Former UFC heavyweight champ has been notified by the US Anti-Doping Agency of a failed out-of-competition drug exam on 28 June
Brock Lesnar has been flagged for a potential anti-doping abuse in the aftermath of his unanimous-decision win over Mark Hunt at UFC 200.
The UFC issued a statement on Friday afternoon saying Lesnar and the advertisement had been notified by the US Anti-Doping Agency of a failed out-of-competition drug measure on 28 June. Usada did not divulge the name of the substance Lesnar tested positive for in keeping with organizational policy.
A embellished amateur wrestler, Lesnar signed with the UFC in 2007 and defeated Randy Couture for the publicities heavyweight championship the following year. He cleared two successful title securities before failing to Cain Velasquez by first-round TKO, then announced his retirement from mixed martial art after a stoppage loss to Alistair Overeem in 2011.
Saturdays fight with Hunt was Lesnars first in five years. The 38 -year-old South Dakota native gave a record $2.5 m purse for the three-round points prevail, with all three judges siding down scores of 29 -2 8.
The UFC said Usada, the independent executive of the organisation anti-doping programme, received the testing results from the 28 June sample accumulation on Thursday evening after it was measured at the Wada-accredited UCLA Olympic Analytical Laboratory.
The original headline bout of Saturdays card a light-colored heavyweight designation oppose between Jon Jones and Daniel Cormier was scrapped when Jones tested positive for a banned element. Cormier instead campaigned Anderson Silva on the undercard, while the womens bantamweight championship engage between Amanda Nunes and Miesha Tate was promoted to the main event.
The UFC 200 main event had to be scrapped three days before the event because Jon Jones tested positive for censored substances in an out-of-competition experiment. Daniel Cormier crusaded Anderson Silva instead. Jones is also awaiting the USADA adjudication process.
Read more: www.theguardian.com